Seegobin K - Search Results

1

Role of Immune Checkpoint Inhibitor Therapy in Advanced EGFR-Mutant Non-Small Cell Lung Cancer.

Wiest N, Majeed U, Seegobin K, Zhao Y, Lou Y, Manochakian R. Wiest N, et al. Among authors: seegobin k. Front Oncol. 2021 Nov 16;11:751209. doi: 10.3389/fonc.2021.751209. eCollection 2021. Front Oncol. 2021. PMID: 34868953 Free PMC article. Review.

2

Patients with high-grade alectinib-induced skin rash: How do we desensitize these patients? A case report and review of literature.

Seegobin K, Majeed U, Lou Y, Zhao Y, Manochakian R. Seegobin K, et al. SAGE Open Med Case Rep. 2020 Oct 24;8:2050313X20966895. doi: 10.1177/2050313X20966895. eCollection 2020. SAGE Open Med Case Rep. 2020. PMID: 33149916 Free PMC article.

3

Macrophage Activation Led Acute Heart Failure Managed Successfully with Immunosuppression.

Seegobin K, Alhaj Moustafa M, Majeed U, Ray JC, Shaikh M, Jiang L, Tun HW. Seegobin K, et al. J Blood Med. 2021 Dec 7;12:1037-1043. doi: 10.2147/JBM.S340361. eCollection 2021. J Blood Med. 2021. PMID: 34916863 Free PMC article.

4

Immunotherapy in Non-Small Cell Lung Cancer With Actionable Mutations Other Than EGFR.

Seegobin K, Majeed U, Wiest N, Manochakian R, Lou Y, Zhao Y. Seegobin K, et al. Front Oncol. 2021 Dec 1;11:750657. doi: 10.3389/fonc.2021.750657. eCollection 2021. Front Oncol. 2021. PMID: 34926258 Free PMC article. Review.

5

Clinical characteristics, prognostic indicators, and survival outcomes in intravascular lymphoma: Mayo Clinic experience (2003-2018).

Seegobin K, Li Z, Alhaj Moustafa M, Majeed U, Wang J, Jiang L, Kuhlman J, Menke D, Li K, Kharfan-Dabaja MA, Ayala E, Iqbal M, Nowakowski GS, Habermann TM, Witzig TE, Johnston P, Thompson C, Ansell S, Tun HW. Seegobin K, et al. Am J Hematol. 2022 Sep;97(9):1150-1158. doi: 10.1002/ajh.26635. Epub 2022 Jul 6. Am J Hematol. 2022. PMID: 35713565 Free PMC article.

6

Genomic landscape of lung adenocarcinomas in different races.

Shi H, Seegobin K, Heng F, Zhou K, Chen R, Qin H, Manochakian R, Zhao Y, Lou Y. Shi H, et al. Among authors: seegobin k. Front Oncol. 2022 Sep 28;12:946625. doi: 10.3389/fonc.2022.946625. eCollection 2022. Front Oncol. 2022. PMID: 36248982 Free PMC article.

7

Lung Cancer in Patients With Lynch Syndrome: Association or Coincidence?

Majeed U, Seegobin K, Lewis J, Li S, Zhao Y, Lou Y, Manochakian R. Majeed U, et al. Among authors: seegobin k. Clin Lung Cancer. 2023 Nov;24(7):e237-e241. doi: 10.1016/j.cllc.2023.05.007. Epub 2023 May 31. Clin Lung Cancer. 2023. PMID: 37336713 Review.

8

Sinonasal renal cell-like adenocarcinoma arising in von Hippel Lindau (VHL) syndrome.

Maharaj S, Seegobin K, Wakeman K, Chang S, Potts K, Williams B, Redman R. Maharaj S, et al. Among authors: seegobin k. Oral Oncol. 2022 Feb;125:105705. doi: 10.1016/j.oraloncology.2021.105705. Epub 2022 Jan 5. Oral Oncol. 2022. PMID: 34998175 Review.

9

Increased risk of arterial thromboembolic events with combination lenalidomide/dexamethasone therapy for multiple myeloma.

Maharaj S, Chang S, Seegobin K, Serrano-Santiago I, Zuberi L. Maharaj S, et al. Among authors: seegobin k. Expert Rev Anticancer Ther. 2017 Jul;17(7):585-591. doi: 10.1080/14737140.2017.1330153. Epub 2017 May 23. Expert Rev Anticancer Ther. 2017. PMID: 28508703 Review.

10

Immune Thrombocytopenia as a Consequence of Rocky Mountain Spotted Fever.

Baldeo C, Seegobin K, Zuberi L. Baldeo C, et al. Among authors: seegobin k. Case Rep Oncol. 2017 Oct 23;10(3):945-947. doi: 10.1159/000481617. eCollection 2017 Sep-Dec. Case Rep Oncol. 2017. PMID: 29279696 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters